PATENT CLAIM ANALYSIS

Application Number: 16016053
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "242000"]

Abstract:
This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein R A  is, for example, a group of the following formula (A-1): wherein ring A 1  is, for example, a cycloalkyl group which may be substituted,and R B  is, for example, a monocyclic cycloalkyl group, or a pharmaceutically acceptable salt thereof.

Claim (Index 11):
The method according to  claim 3 ,\n wherein\n R B7  is a cycloalkyl group which may be substituted, \n wherein a substituent of the cycloalkyl group which may be substituted is 1-2 groups selected independently from the group consisting of a hydroxyl group; an aliphatic heterocyclic group which may be substituted with 1-3 groups selected independently from the group consisting of a hydroxyl group and an oxo group; an amino group which may be substituted with 1-2 groups selected independently from the group consisting of an alkyl group which may be substituted with an alkylsulfonyl group, and an alkanoyl group; an alkyl group which may be substituted with a hydroxyl group; a carbamoyl group which may be substituted with 1-2 alkyl groups; an alkoxy group which may be substituted with a carbamoyl group which may be substituted with 1-2 alkyl groups; a cycloalkyl group which may be substituted with a hydroxyl group; and an alkylsulfonyl group, or \n two substituents on the same carbon atom in the above cycloalkyl group which may be substituted are bound to each other at the terminus thereof to form an alkylene group which may be substituted with 1-3 groups selected independently from the group consisting of an alkyl group and an oxo group (wherein the alkylene group may contain, in the alkylene chain, 1-2 heteroatoms selected independently from a nitrogen atom, an oxygen atom, and a sulfur atom), \n wherein the aliphatic heterocyclic group is pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, or thiomorpholinyl, and \n a cycloalkyl moiety of the above cycloalkyl group which may be substituted is cyclobutyl, cyclopentyl, cyclohexyl, bicyclo[2.2.2]octyl, or adamantly.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 94.0
- Lexical Diversity: 1.76056
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15305587', '15313407', '13201536', '11363563', '14619980']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8184815051898252
- 35 USC 102 Novelty (BERT): 0.5838893071791658
- Combined Prediction Score: 0.7950222853887593
- Mean Citation Score: 313.52282600000007
- Max Citation Score: 484.2341
- Similarity Product: 453.33264431009286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test